Thursday, February 4, 2016
Abbott has announced a definitive agreement to acquire Alere, significantly advancing Abbott’s global diagnostics presence and leadership. Abbott will pay $56 per common share at a total expected equity value of $5.8 billion. Once the transaction is completed, Abbott will become a leading diagnostics provider of point-of-care testing. Abbott’s total diagnostics sales will exceed $7 billion after the close.